Microba Life Sciences Balance Sheet Health
Financial Health criteria checks 5/6
Microba Life Sciences has a total shareholder equity of A$49.2M and total debt of A$118.1K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are A$65.2M and A$16.0M respectively.
Key information
0.2%
Debt to equity ratio
AU$118.10k
Debt
Interest coverage ratio | n/a |
Cash | AU$28.05m |
Equity | AU$49.25m |
Total liabilities | AU$15.99m |
Total assets | AU$65.24m |
Financial Position Analysis
Short Term Liabilities: MAP's short term assets (A$42.5M) exceed its short term liabilities (A$13.0M).
Long Term Liabilities: MAP's short term assets (A$42.5M) exceed its long term liabilities (A$3.0M).
Debt to Equity History and Analysis
Debt Level: MAP has more cash than its total debt.
Reducing Debt: Insufficient data to determine if MAP's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MAP has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MAP has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 31.6% each year.